Sanofi, a global biopharmaceutical company based in France, manufactures drugs to treat diabetes, meningitis and various forms of cancer. The company has also manufactured a vaccine to prevent COVID-19 infections, which was recently found to be effective against Omicron-related cases, according to Reuters.
Months into the COVID-19 pandemic, researchers observed an uptick in mobile phishing attempts targeting the pharmaceutical industry. Cyberattack trends have led to the hardening of pharmaceutical companies' attack surfaces.